Urogen Pharma Ltd (URGN)

R&D Expenses

$61.26M

TTM · Period ending: · USD

URGN logo

URGN R&D Expenses

Latest reported$61.26M
URGN R&D Expenses ($2.33M → $61.26M)
High-resolution chart · PNG

URGN r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
67,107,000
57,145,000
45,614,000
52,906,000
47,642,000
47,310,000
49,297,000
36,934,000
18,697,000
10,287,000
10,515,000
4,008,000
2,334,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.